Acquired Tertiary MET Resistance (MET D1228N and a Novel LSM8-MET Fusion) to Selpercatinib and Capmatinib in a Patient With KIF5B-RET-positive NSCLC With Secondary MET Amplification as Initial Resistance to Selpercatinib.

Viola W Zhu, Shannon S Zhang, Jian Zhang, Jeffrey Swensen, Joanne Xiu, Sai-Hong Ignatius Ou

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Jul

filter terms:

No abstract available.

Citation

Viola W Zhu, Shannon S Zhang, Jian Zhang, Jeffrey Swensen, Joanne Xiu, Sai-Hong Ignatius Ou. Acquired Tertiary MET Resistance (MET D1228N and a Novel LSM8-MET Fusion) to Selpercatinib and Capmatinib in a Patient With KIF5B-RET-positive NSCLC With Secondary MET Amplification as Initial Resistance to Selpercatinib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021 Jul;16(7):e51-e54